Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin

Respiratory Medicine

Volumn 101, Issue 7, 2007, Pages 1447-1454

  Xu, Junyang ^a   Jiang, Fengxia ^a   Nayeri, Fariba ^b   Zetterström, Olle ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Asthma; Eosinophil; Eotaxin; Interleukin 5; Sputum

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; EOSINOPHIL CATIONIC PROTEIN; EOTAXIN; INTERLEUKIN 5; THEOPHYLLINE;

ADULT; AGED; APOPTOSIS; ARTICLE; ASTHMA; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CONTROL; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ASTHMA; BIOLOGICAL MARKERS; CHEMOKINES, CC; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-5; MALE; MAXIMAL MIDEXPIRATORY FLOW RATE; MIDDLE AGED; SPECIMEN HANDLING; SPUTUM;

EID: 34249715385     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.01.026     Document Type: Article

References (26)

1. Frigas E., and Gleich G.J. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 77 (1986) 527-537
2. Fleisher T.A. Apoptosis. Ann Allergy Asthma Immunol 78 (1997) 245-249
3. Adachi T., Motojima S., Hirata A., Fukuda T., and Makino S. Eosinophil viability enhancing activity in sputum from patients with bronchial asthma: contribution of interleukin-5 and granulocyte macrophage colony-stimulating factor. Am J Respir Crit Care Med 151 (1995) 618-623
4. Hadjicharalambous C., Dent G., May R.D., Handy R.L., Anderson I.K., Davies D.E., et al. Measurement of eotaxin (CCL11) in induced sputum supernatants: validation and detection in asthma. J Allergy Clin Immunol 113 (2004) 657-662
5. Brown J.R., Kleimberg J., Marini M., Sun G., Bellini A., and Mattoli S. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol 114 (1998) 137-146
6. Yamada H., Yamaguchi M., Yamamoto K., Nakajima T., Hirai K., Morita Y., et al. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum. Allergy 55 (2000) 392-397
7. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2002 Revision. National Institutes of Health, National Heart, Lung, and Blood Institute. 〈www.ginasthma.com/workshop.pdf〉. Date updated: April 2002. Date accessed: 13 November 2002.
8. Pizzichini E., Pizzichini M.M., Efthimiadis A., Evans S., Morris M.M., Squillace D., et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluidphase measurements. Am J Respir Crit Care Med 154 (1996) 308-317
9. Simon H.U., and Blaser K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?. Immunol Today 16 (1995) 53-55
10. Owen Jr. W.F., Rothenberg M.E., Silberstain D.S., Gasson J.C., Stevens R.L., Austen K.F., et al. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 166 (1987) 129-141
11. Rothenberg M.E., Owen Jr. W.F., Silberstein D.S., Woods J., Sobermen R.J., Austen K.F., et al. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 81 (1988) 1986-1992
12. Simon H.U., Yousefi S., Schranz C., Schpowal A., Bachert C., and Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 158 (1997) 3902-3908
13. Walker C., Virchow J.C., Bruijnzeel P.L., and Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 146 (1991) 1829-1835
14. Chinen J., and Shearer W.T. Advances in asthma, allergy and immunology series 2004: basic and clinical immunology. J Allergy Clin Immunol 114 (2004) 398-405
15. De Monchy J.G.R., Kauffman H.F., Venge P., Koëter G.H., Jansen H.M., Sluiter H.J., et al. Bronchoalveolar eosinophilia during allergeninduced late asthmatic reactions. Am Rev Respir Dis 131 (1985) 373-376
16. Menzies-Gow A., and Robinson D.S. Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma. Curr Opin Pulm Med 8 (2002) 33-38
17. Zagai U., Skold C.M., Trulson A., Venge P., and Lundahl J. The effect of eosinophils on collagen gel contraction and implications for tissue remodelling. Clin Exp Immunol 135 (2004) 427-433
18. Vargaftig B.B. Modifications of experimental bronchopulmonary hyperresponsiveness. Am J Respir Crit Care Med 156 (1997) S97-S102
19. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E., Longthorne V.L., Culhane A.C., et al. Apoptosis: molecular regulation of cell death. Eur J Biochem 236 (1996) 1-26
20. Maa S.H., Wang C.H., Liu C.Y., Lin H.C., Huang K.H., and Kuo H.P. Endogenous nitric oxide downregulates the Bcl-2 expression of eosinophils through mitogen-activated protein kinase in bronchial asthma. J Allergy Clin Immunol 112 (2003) 761-767
21. Dewson G., Walsh G.M., and Wardlaw A.J. Expression of Bcl-2 and its homologues in human eosinophils Modulation by interleukin-5. Am J Respir Cell Mol Biol 20 (1999) 720-728
22. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. New Engl J Med 323 (1990) 1033-1039
23. Conroy D.M., and Williams T.J. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2 (2001) 150-156
24. Bumbacea D., Scheerens J., Mann B.S., Stirling R.G., and Chung K.F. Failure of sputum eosinophilia after eotaxin inhalation in asthma. Thorax 59 (2004) 372-375
25. Zeibecoglou K., Ying S., Meng Q., Kay A.B., Robinson D.S., and Papageorgiou N. Expression of eotaxin in induced sputum of atopic and nonatopic asthmatics. Allergy 55 (2000) 1042-1048
26. Seton K., Hakansson L., Karawajczyk M., and Venge P. The stimulus-dependent release of eosinophil cationic protein and eosinophil protein x increases in apoptotic eosinophils. Scand J Immunol 58 (2003) 312-320